Sanofi to sell 51% stake in Opella
Sanofi enters exclusive talks with CD&R for Opella sale
Sanofi said on Monday it had entered exclusive talks for the sale of a 50% controlling stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice (CD&R). The French pharmaceutical company,
Sanofi Enters Exclusive Negotiations To Sell 50% Stake In Opella To CD&R
Sanofi (SNYNF) announced it has entered into exclusive negotiations to sell a 50 percent controlling stake in its consumer healthcare
Sanofi Sells Controlling Stake in Opella to CD&R with Job Guarantees
CD&R is nearing a deal to acquire control of Sanofi’s consumer health unit after it signed social commitments with the French government.
Sanofi Enters Exclusive Talks With CD&R Over Opella Stake Sale
Sanofi entered into exclusive talks to sell a controlling stake in its consumer-healthcare business Opella to Clayton Dubilier & Rice in a deal that values the business as a whole at 16 billion euros ($17.
Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI, Reuters reports
France will take a stake in Sanofi’s Opella through the Public Investment Bank, or BPI, finance minister Antoine Armand said on Sunday, confirming an information from Le Figaro
Sanofi Enters Exclusive Talks to Sell 50% Stake in Opella to CD&R
Sanofis Exclusive Negotiations with Clayton Dubilier Rice Sanofi (NASDAQ: SNY) announced on Monday that it has entered exclusive negotiations to sell a 50% controlling stake in its consumer health division,
Sanofi, CD&R in Exclusive Negotiations for Sale, Purchase of 50% Stake in Opella
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing opportunities, strengthen advisor-client relationships and build investor experiences. Learn More. Back To Top
Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI
France will take a stake in Sanofi's Opella through the Public Investment Bank (BPI), finance minister Antoine Armand said on Sunday, confirming an information from Le Figaro newspaper that U.S. private equity firm Clayton Dubilier & Rice (CD&R) is to take a 51% stake in the company that makes of one of France's most-sold painkillers,
Sanofi in exclusive talks with CD&R over sale of $17 billion Opella
PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its ...
Sanofi Pursues Sale Of Painkiller After Political Controversy
Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, after employment and investment guarantees relieved political controversy.
Daily36m
Sanofi closes deal for consumer health unit Opella: Report
The breakthrough came after the investment group provided France with guarantees on maintaining jobs and production in the ...
Sanofi Set to Sign Consumer Health Deal With CD&R This Weekend
Sanofi is aiming to sign an agreement this weekend to sell control of its consumer health business to Clayton Dubilier & Rice ...
Sanofi and CD&R enter exclusive talks for Opella sale
Sanofi (EPA:SASY)(NASDAQ:SNY) has entered into exclusive negotiations with private equity firm Clayton, Dubilier&Rice to sell ...
Sanofi reaches deal on terms of sale of consumer health arm, say French government sources
Sanofi on Sunday reached an agreement on terms to sell a controlling stake in its consumer health unit Opella to U.S. private ...
PAI Partners to Raise Offer for Sanofi’s Consumer Unit
PAI Partners has submitted an improved offer for Sanofi’s consumer health business, according to people familiar with the ...
France's PAI Partners Ups Bid for Sanofi's Consumer Health Division As French Government Hints Possible Regulatory Block
Sanofi is in talks with CD&R to sell a 50% stake in its consumer healthcare unit, Opella. PAI Partners raised its bid by 200 ...